Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses

Purpose Several meta-analyses have reported data about the diagnostic performance of positron emission tomography or positron emission tomography/computed tomography (PET or PET/CT) with different radiotracers in patients with suspicious lung cancer (LC) or pleural tumours (PT). This review article aims at providing an overview on the recent evidence-based data in this setting. Methods A comprehensive literature search of meta-analyses published in PubMed/MEDLINE and Cochrane Library database from January 2010 through March 2020 about the diagnostic performance of PET or PET/CT with different radiotracers in patients with suspicious LC or PT was performed. This combination of keywords was used: (A) “PET” OR “positron emission tomography” AND (B) “lung” OR “pulmonary” OR “pleur∗” AND (C) meta-analysis. Only meta-analyses on PET or PET/CT in patients with suspicious LC or PT were selected. Results We have summarized the diagnostic performance of PET or PET/CT with fluorine-18 fluorodeoxyglucose (18F-FDG) and other radiotracers taking into account 17 meta-analyses. Evidence-based data demonstrated a good diagnostic performance of 18F-FDG PET or PET/CT for the characterization of solitary pulmonary nodules (SPNs) or pleural lesions with overall higher sensitivity than specificity. Evidence-based data do not support the routine use of dual time point (DTP) 18F-FDG PET/CT or fluorine-18 fluorothymidine (18F-FLT) PET/CT in the differential diagnosis of SPNs. Even if 18F-FDG PET/CT has high sensitivity and specificity as a selective screening modality for LC, its role in this setting remains unknown. Conclusions Evidence-based data about the diagnostic performance of PET/CT with different radiotracers for suspicious LC or PT are increasing, with good diagnostic performance of 18F-FDG PET/CT. More prospective multicenter studies and cost-effectiveness analyses are warranted.

[1]  Jiapeng Li,et al.  Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis. , 2019, Journal of thoracic disease.

[2]  M. Alloisio,et al.  Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomography , 2019, Nuclear medicine communications.

[3]  A. Garcez,et al.  Fluorine 18-FDG PET/CT and Diffusion-weighted MRI for Malignant versus Benign Pulmonary Lesions: A Meta-Analysis. , 2019, Radiology.

[4]  Zhenzhen Li,et al.  The value of 18F-FDG-PET/CT in the diagnosis of solitary pulmonary nodules , 2018, Medicine.

[5]  R. Crisci,et al.  Diagnostic performance of fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a meta-analysis. , 2018, Journal of thoracic disease.

[6]  G. Treglia,et al.  Systematic reviews and meta-analyses of diagnostic studies: a practical guideline , 2017, Clinical and Translational Imaging.

[7]  Yongfu Ma,et al.  A meta-analysis to evaluate the diagnostic value of dual-time-point F-fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of pulmonary nodules. , 2016, Journal of cancer research and therapeutics.

[8]  K. C. de Lima,et al.  Solitary pulmonary nodule and 18F-FDG PET/CT. Part 2: accuracy, cost-effectiveness, and current recommendations* , 2016, Radiologia brasileira.

[9]  Wei Zhang,et al.  Performance of FLT-PET for pulmonary lesion diagnosis compared with traditional FDG-PET: A meta-analysis. , 2015, European journal of radiology.

[10]  Juan Zhao,et al.  Analysis on early detection of lung cancer by PET/CT scan. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[11]  J. M. Porcel,et al.  Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis. , 2015, Chest.

[12]  M. Aldrich,et al.  Cost-effectiveness of initial diagnostic strategies for pulmonary nodules presenting to thoracic surgeons. , 2014, The Annals of thoracic surgery.

[13]  Melissa L McPheeters,et al.  Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. , 2014, JAMA.

[14]  L. Giovanella,et al.  Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in the Postchemotherapy Management of Patients with Seminoma: Systematic Review and Meta-Analysis , 2014, BioMed research international.

[15]  A. Del Sole,et al.  Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review , 2014, Clinical and Translational Oncology.

[16]  L. Moodley,et al.  Approach to a solid solitary pulmonary nodule in two different settings-"Common is common, rare is rare". , 2014, Journal of thoracic disease.

[17]  John O. Prior,et al.  Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis. , 2014, Lung Cancer.

[18]  C. Chien,et al.  Fluorodeoxyglucose-positron emission tomography screening for lung cancer : a systematic review and meta-analysis , 2013 .

[19]  J. Lei,et al.  Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis , 2013, Acta radiologica.

[20]  G. Treglia,et al.  Recent applications of nuclear medicine in diagnostics (I part) , 2013 .

[21]  G. Treglia,et al.  Meta-analyses and systematic reviews on PET and PET/CT in oncology: the state of the art , 2013, Clinical and Translational Imaging.

[22]  Ji-An Liang,et al.  Potential value of dual-time-point 18F-FDG PET compared with initial single-time-point imaging in differentiating malignant from benign pulmonary nodules: a systematic review and meta-analysis , 2012, Nuclear medicine communications.

[23]  A. Louie,et al.  Systematic review of the cost-effectiveness of positron-emission tomography in staging of non--small-cell lung cancer and management of solitary pulmonary nodules. , 2012, Clinical lung cancer.

[24]  K. Nandalur,et al.  Diagnostic performance of dual-time 18F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis. , 2012, Academic radiology.

[25]  M. Boers,et al.  The need for Health Technology Assessments of PET , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  W. Xiaohong,et al.  Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis , 2017, Nuclear medicine communications.

[27]  Wengui Xu,et al.  Comparison of the diagnostic performance of 18F-fluorothymidine versus 18F-fluorodeoxyglucose positron emission tomography on pulmonary lesions: A meta analysis. , 2015, Molecular and clinical oncology.

[28]  John O. Prior,et al.  Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis. , 2014, Academic radiology.